BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 17137717)

  • 1. Circulating nucleic acids (CNAs) and cancer--a survey.
    Fleischhacker M; Schmidt B
    Biochim Biophys Acta; 2007 Jan; 1775(1):181-232. PubMed ID: 17137717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies?
    Anker P; Mulcahy H; Stroun M
    Int J Cancer; 2003 Jan; 103(2):149-52. PubMed ID: 12455027
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating nucleic acids as a tumor marker.
    Chan KC; Lo YM
    Histol Histopathol; 2002; 17(3):937-43. PubMed ID: 12168805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma nucleic acids in the diagnosis and management of malignant disease.
    Johnson PJ; Lo YM
    Clin Chem; 2002 Aug; 48(8):1186-93. PubMed ID: 12142371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating DNA in plasma or serum.
    Anker P; Stroun M
    Medicina (B Aires); 2000; 60(5 Pt 2):699-702. PubMed ID: 11188885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology.
    Gold B; Cankovic M; Furtado LV; Meier F; Gocke CD
    J Mol Diagn; 2015 May; 17(3):209-24. PubMed ID: 25908243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
    Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
    Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients.
    Domínguez G; Carballido J; Silva J; Silva JM; García JM; Menéndez J; Provencio M; España P; Bonilla F
    Clin Cancer Res; 2002 Apr; 8(4):980-5. PubMed ID: 11948103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free circulating nucleic acids in plasma and serum (CNAPS) -- Useful for the detection of lung cancer patients?
    Fleischhacker M; Schmidt B
    Cancer Biomark; 2010; 6(3-4):211-9. PubMed ID: 20660966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating nucleic acids in plasma or serum.
    Anker P; Lyautey J; Lederrey C; Stroun M
    Clin Chim Acta; 2001 Nov; 313(1-2):143-6. PubMed ID: 11694252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New markers for cancer detection.
    Wong IH; Lo YM
    Curr Oncol Rep; 2002 Nov; 4(6):471-7. PubMed ID: 12354358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
    Bremnes RM; Sirera R; Camps C
    Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating nucleic acids and proteomics of plasma/serum: clinical utility.
    Taback B; Hoon DS
    Ann N Y Acad Sci; 2004 Jun; 1022():1-8. PubMed ID: 15251932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARMS allele-specific amplification-based detection of mutant p53 DNA and mRNA in tumors of the breast.
    Hodgson DR; Clayton SJ; Girdler F; Brotherick I; Shenton B; Browell D; Stuart M; Fox JC; Ceuppens P; Foy CA; Whitcombe D; Gibson NJ
    Clin Chem; 2001 Apr; 47(4):774-8. PubMed ID: 11274040
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic potential of circulating nucleic acids for oncology.
    Goessl C
    Expert Rev Mol Diagn; 2003 Jul; 3(4):431-42. PubMed ID: 12877383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantitative analysis of circulating DNA in serum of cancer patients].
    Tu H; Gao HF; Fu SL; Chen H
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):606-8. PubMed ID: 15634521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of genetic alterations in the serum of colorectal cancer patients.
    Hibi K; Robinson CR; Booker S; Wu L; Hamilton SR; Sidransky D; Jen J
    Cancer Res; 1998 Apr; 58(7):1405-7. PubMed ID: 9537240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating DNA: a new diagnostic gold mine?
    Ziegler A; Zangemeister-Wittke U; Stahel RA
    Cancer Treat Rev; 2002 Oct; 28(5):255-71. PubMed ID: 12435372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating nucleic acids in plasma and serum: past, present and future.
    Taback B; Hoon DS
    Curr Opin Mol Ther; 2004 Jun; 6(3):273-8. PubMed ID: 15264429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer.
    Grady WM; Rajput A; Lutterbaugh JD; Markowitz SD
    Cancer Res; 2001 Feb; 61(3):900-2. PubMed ID: 11221878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.